Romiplostim as early treatment for refractory primary immune thrombocytopenia

Author： Contis Anne   Lazaro Estibaliz   Greib Carine   Pellegrin Jean-Luc   Viallard Jean-François  

Publisher： Springer Publishing Company

ISSN： 0925-5710

Source： International Journal of Hematology, Vol.98, Iss.5, 2013-11, pp. : 520-524

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Reduced corticosteroid use in adult patients with primary immune thrombocytopenia receiving romiplostim

By Michel Marc   te Boekhorst PeterA W   Janssens Ann   Pabinger-Fasching Ingrid   Sanz MiguelA   Nie Kun   Kreuzbauer Georg  

Hematology, Vol. 16, Iss. 5, 2011-09 ,pp. : 274-277

Maney Publishing

Access to resources Recommend Favorite

Pathophysiology and management of primary immune thrombocytopenia

By Kashiwagi Hirokazu   Tomiyama Yoshiaki  

International Journal of Hematology, Vol. 98, Iss. 1, 2013-07 ,pp. : 24-33

Springer Publishing Company

Access to resources Recommend Favorite

Immune thrombocytopenia

By Provan Drew  

Hematology, Vol. 18, Iss. 4, 2013-07 ,pp. : 242-243

Maney Publishing

Access to resources Recommend Favorite

Erratum to: Chronic adult primary immune thrombocytopenia (ITP) in the Asia-Pacific region

By Lee Lai   Caguioa Priscilla   Chin Ng   Chiou Tzeon-Jye   Lee Jong   Miyakawa Yoshitaka   Tambunan Karmel   Chong Beng  

International Journal of Hematology, Vol. 98, Iss. 6, 2013-12 ,pp. : 729-729

Springer Publishing Company

Access to resources Recommend Favorite

Anti-CD52 Antibody-Mediated Immune Ablation with Autologous Immune Recovery for the Treatment of Refractory Juvenile Polymyositis

By Reiff Andreas  

Journal of Clinical Immunology, Vol. 31, Iss. 4, 2011-08 ,pp. : 615-622

Springer Publishing Company

Access to resources Recommend Favorite